A comparison of TG-43 and TG-186 dose calculation algorithms for treatment planning of intra-cavitary brachytherapy using tandem and ovoid applicator.

J Contemp Brachytherapy · 2024 · PMC11609851 · PMID 39628821

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

The analysis revealed a marginal 0.02% increase in PQI 1 for TG-186 compared with TG-43, encompassing indices, such as CI, COIN, and DHI, primarily associated with HR-CTV, which did not reach statistical significance ( p > 0.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.